It seems therefore that inhibition of p110δ in B-CLL in vivo is more efficient to release B-CLL from their microenvironment than to kill them which is consistent with recent data showing that even extremely reduced levels of class I PI3K activity are sufficient to sustain cell survival (Foukas et al., 2010). The gene discussed is PIK3CD; the disease is B-cell chronic lymphocytic leukemia.